Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$8.49−0.21 (-2.41%)
Close on Nov 17, 2026Market cap $1.55BP/E –Yield –
Teladoc Health total assets
Total assets on the balance sheet at the end of each period.
Teladoc Health's total assets was $2.78B at Sep 30, 2026. For fiscal 2025 it was $2.86B, down 18.7% from the year before. Over ten years it grew 28.7% a year on average. The highest annual figure on record is $17.76B in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.86B | -18.7% |
| FY2024 | Dec 31, 2024 | $3.52B | -19.9% |
| FY2023 | Dec 31, 2023 | $4.39B | +1.1% |
| FY2022 | Dec 31, 2022 | $4.35B | -75.5% |
| FY2021 | Dec 31, 2021 | $17.73B | -0.1% |
| FY2020 | Dec 31, 2020 | $17.76B | +1007.7% |
| FY2019 | Dec 31, 2019 | $1.60B | +4.8% |
| FY2018 | Dec 31, 2018 | $1.53B | +85.5% |
| FY2017 | Dec 31, 2017 | $824.39M | +171.5% |
| FY2016 | Dec 31, 2016 | $303.67M | +32.2% |
| FY2015 | Dec 31, 2015 | $229.74M | +150.2% |
| FY2014 | Dec 31, 2014 | $91.84M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.78B | -3.6% |
| Q2 FY2026 | Jun 30, 2026 | $2.76B | -4.7% |
| Q1 FY2026 | Mar 31, 2026 | $2.81B | -18.5% |
| Q4 FY2025 | Dec 31, 2025 | $2.86B | -18.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.88B | -18.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.89B | -17.9% |
| Q1 FY2025 | Mar 31, 2025 | $3.44B | -20.3% |
| Q4 FY2024 | Dec 31, 2024 | $3.52B | -19.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.53B | -18.5% |
| Q2 FY2024 | Jun 30, 2024 | $3.52B | -18.4% |
| Q1 FY2024 | Mar 31, 2024 | $4.32B | +0.3% |
| Q4 FY2023 | Dec 31, 2023 | $4.39B | +1.1% |
| Q3 FY2023 | Sep 30, 2023 | $4.33B | -46.6% |
| Q2 FY2023 | Jun 30, 2023 | $4.32B | -46.7% |
| Q1 FY2023 | Mar 31, 2023 | $4.31B | -61.2% |
| Q4 FY2022 | Dec 31, 2022 | $4.35B | -75.5% |
| Q3 FY2022 | Sep 30, 2022 | $8.10B | -54.1% |
| Q2 FY2022 | Jun 30, 2022 | $8.10B | -54.0% |
| Q1 FY2022 | Mar 31, 2022 | $11.09B | -36.9% |
| Q4 FY2021 | Dec 31, 2021 | $17.73B | -0.1% |
| Q3 FY2021 | Sep 30, 2021 | $17.65B | +411.8% |
| Q2 FY2021 | Jun 30, 2021 | $17.61B | +628.1% |
| Q1 FY2021 | Mar 31, 2021 | $17.58B | +996.8% |
| Q4 FY2020 | Dec 31, 2020 | $17.76B | +1007.7% |
| Q3 FY2020 | Sep 30, 2020 | $3.45B | +119.9% |
| Q2 FY2020 | Jun 30, 2020 | $2.42B | +54.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.60B | +3.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.60B | +4.8% |
| Q3 FY2019 | Sep 30, 2019 | $1.57B | +2.2% |
| Q2 FY2019 | Jun 30, 2019 | $1.57B | +30.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.55B | +89.8% |
| Q4 FY2018 | Dec 31, 2018 | $1.53B | +85.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.54B | +74.3% |
| Q2 FY2018 | Jun 30, 2018 | $1.20B | +78.0% |
| Q1 FY2018 | Mar 31, 2018 | $817.52M | +97.5% |
| Q4 FY2017 | Dec 31, 2017 | $824.39M | +171.5% |
| Q3 FY2017 | Sep 30, 2017 | $880.92M | – |
| Q2 FY2017 | Jun 30, 2017 | $674.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $413.95M | – |
| Q4 FY2016 | Dec 31, 2016 | $303.67M | – |
See a number that looks wrong?